$250 | Single User
$500 | Site License
$750 | Global License

National Heart Lung and Blood Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-04-2018]

Published by Global Data: 23 Apr 2018 | 208799 | In Stock

Introduction

Summary

National Heart Lung and Blood Institute (NHLBI), a subsidiary of National Institutes of Health is a medical research institute that provides treatment for heart, lung, and blood diseases.The institute conducts research studies with patients who have diseases of heart and blood vessels, lungs, blood cells and bone marrow, and cholesterol. It develops health education and awareness programs to effect positive change in public health. NHLBI operates different divisions for cardiovascular sciences, lung diseases, blood diseases and resources;and a division for intramural research and division for application of research discoveries. The institute works in collaboration with patients, scientists, professional societies, health care professionals, community organizations, and patient advocacy groups. NHLBI is headquartered in Bethesda, Maryland, the US.

National Heart Lung and Blood Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for National Heart Lung and Blood Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-04-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    National Heart Lung and Blood Institute, Medical Devices Deals, 2012 to YTD 2018 9

    National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

    National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deal Details 11

    Partnerships 11

    New England Research Institutes Enters into Research Agreement with National Heart Lung and Blood Institute 11

    Protein Foundry Enters into Research Contract with NHLBI 12

    WiCell Research Institute Enters into Distribution Agreement with NHLBI 13

    National Heart Lung and Blood Institute - Key Competitors 14

    National Heart Lung and Blood Institute - Key Employees 15

    National Heart Lung and Blood Institute - Locations And Subsidiaries 16

    Head Office 16

    Recent Developments 17

    Government and Public Interest 17

    Apr 12, 2018: LJI Researchers are One Step Closer to an Effective Anti-Atherosclerosis Vaccine 17

    Apr 04, 2018: NEOMED Researcher Receives .5 Million NIH Grant to Study Atherosclerosis 18

    Apr 02, 2018: New technique makes heart valve replacement safer for some high-risk patients 19

    Mar 26, 2018: Diuretic therapy for extremely preterm infants does not alleviate respiratory problems 20

    Mar 11, 2018: Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure 21

    Mar 05, 2018: Short-term increases in inhaled steroid doses do not prevent asthma flare-ups in children 23

    Feb 27, 2018: HealthPartners Institute study uses pharmacists to improve patient outcomes 24

    Feb 08, 2018: NIH funding to improve devices and safeguard cardiovascular health 25

    Jan 19, 2018: Researchers Analyze Big Data, Aim for Lung Disease Precision Treatment Improvement 26

    Jan 18, 2018: Albany Medical College Wins .9 Million NIH Grant for Studies on Flu Complications 28

    Jan 03, 2018: Cellular barcoding helps scientists understand the behavior of stem cells 29

    Nov 14, 2017: .5M Grant Awarded to Improve Asthma Care with the Navajo Nation 30

    Nov 14, 2017: Hospital awarded .9M grant for pediatric asthma care 31

    Nov 04, 2017: Enzyme identified as therapeutic target for ocular neovascularization 32

    Sep 28, 2017: Neuro-Immune Crosstalk in Allergic Asthma 33

    Sep 27, 2017: NIH announces centers for myalgic encephalomyelitis/chronic fatigue syndrome research 35

    Sep 15, 2017: LSUHealthNO to Study New Drug to Regenerate Heart Muscle 37

    Sep 07, 2017: Senators Collins, King Announce 9,681 in Funding to Novo Biosciences for Heart and Vascular Disease Research 38

    May 22, 2017: COPD National Action Plan aims to reduce the burden of the third leading cause of death 39

    Appendix 40

    Methodology 40

    About GlobalData 40

    Contact Us 40

    Disclaimer 40

List Of Tables
in National Heart Lung and Blood Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-04-2018]

List of Tables

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Key Facts 2

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

National Heart Lung and Blood Institute, Deals By Therapy Area, 2012 to YTD 2018 8

National Heart Lung and Blood Institute, Medical Devices Deals, 2012 to YTD 2018 9

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

New England Research Institutes Enters into Research Agreement with National Heart Lung and Blood Institute 11

Protein Foundry Enters into Research Contract with NHLBI 12

WiCell Research Institute Enters into Distribution Agreement with NHLBI 13

National Heart Lung and Blood Institute, Key Competitors 14

National Heart Lung and Blood Institute, Key Employees 15

List Of Figures, Charts and Diagrams
in National Heart Lung and Blood Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-04-2018]

List of Figures

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

National Heart Lung and Blood Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

National Heart Lung and Blood Institute, Medical Devices Deals, 2012 to YTD 2018 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

208799 | GDPH40743D

Number of Pages

40

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Lawrence Livermore National Laboratory - Medical Equipment - Deals and Alliances Profile
SummaryLawrence Livermore National Laboratory (LLNL) is a national security technology provider. The...
25 Feb 2016 by Global Data USD $250 More Info
National University of Singapore - Medical Equipment - Deals and Alliances Profile
SummaryNational University of Singapore (NUS) is an educational institution that provides education ...
25 Feb 2016 by Global Data USD $250 More Info
Centre National de la Recherche Scientifique - Medical Equipment - Deals and Alliances Profile
SummaryCentre National de la Recherche Scientifique (CNRS) is an educational center that offers rese...
24 Feb 2016 by Global Data USD $250 More Info
National HealthCare Corporation (NHC) - Financial and Strategic SWOT Analysis Review
SummaryNational HealthCare Corporation (NHC) is a health care service provider that offers home-care...
09 Jan 2016 by Global Data USD $300 More Info
National Research Corporation (NRCIB) - Financial and Strategic SWOT Analysis Review
SummaryNational Research Corporation (NRC) is a healthcare organization that provides patient-center...
09 Jan 2016 by Global Data USD $300 More Info
National HealthCare Corporation (NHC) - Financial and Strategic SWOT Analysis Review
SummaryNational HealthCare Corporation (NHC) is a health care service provider that offers home-care...
08 Nov 2015 by Global Data USD $300 More Info
National Research Corporation (NRCIB) - Financial and Strategic SWOT Analysis Review
SummaryNational Research Corporation (NRC) is a healthcare organization that provides patient-center...
08 Nov 2015 by Global Data USD $300 More Info
Lawrence Livermore National Laboratory - Medical Equipment - Deals and Alliances Profile
SummaryLawrence Livermore National Laboratory (LLNL) is a national security technology provider. The...
23 Oct 2015 by Global Data USD $250 More Info
National Cancer Institute - Medical Equipment - Deals and Alliances Profile
SummaryNational Cancer Institute (NCI), a subsidiary of National Institutes of Health is a cancer re...
23 Oct 2015 by Global Data USD $250 More Info
Institut National de la Sante et de la Recherche Medicale - Medical Equipment - Deals and Alliances Profile
SummaryInstitut National de la Sante et de la Recherche Medicale (Inserm) is a medical research inst...
16 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

National Heart Lung and Blood Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-04-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data